Financhill
Back

CRISPR Therapeutics AG Vs. Editas Medicine Industry Stock Comparison

Sell
42

CRSP
CRISPR Therapeutics AG

Last Price:
48.19
Seasonality Move:
3.26%
Sell
37

EDIT
Editas Medicine

Last Price:
3.77
Seasonality Move:
10.81%
Sell
42
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $48.23. The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.77. The Score for EDIT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $48.23
    The current trend is relatively stagnant and CRSP is experiencing slight selling pressure.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 49.65 Sell
Chaikin Money Flow: -473561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.83 - 49.31) Buy
Bollinger Bands (100): (48.6 - 58.54) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 44.16 Sell
Chaikin Money Flow: -268969 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.62 - 3.96) Sell
Bollinger Bands (100): (4.08 - 5.62) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.15 Buy
20-day SMA: 47.25 Buy
50-day SMA: 50.65 Sell
200-day SMA: 60.65 Sell
8-day EMA: 48.26 Sell
20-day EMA: 47.95 Buy
50-day EMA: 50.07 Sell
200-day EMA: 56.19 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.84 Sell
20-day SMA: 3.74 Buy
50-day SMA: 4.38 Sell
200-day SMA: 6.55 Sell
8-day EMA: 3.82 Sell
20-day EMA: 3.85 Sell
50-day EMA: 4.24 Sell
200-day EMA: 6.02 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):